Company:  HEAT BIOLOGICS, INC. (HTBX)
Form Type:  8-K
Filing Date:  12/7/2017 
CIK:  0001476963 
Address:  801 CAPITOLA DRIVE 
City, State, Zip:  DURHAM, North Carolina 27713 
Telephone:  919-240-7133 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.11  
Change: 
-0.11 (-9.02%)  
Trade Time: 
Apr 20  
Market Cap: 
$6.29M
Trade HTBX now with 

© 2018  
Description of Business
We are a biopharmaceutical company developing approaches to activate and co-stimulate a patient's immune system against cancer. Our co-stimulatory antibody is designed to harness the body's natural antigen specific immune activation and tolerance mechanisms to reprogram the immunity and provide a long-term, durable clinical effect. Our T-cell activating platform (TCAP) produces therapies designed to turn immunologically "cold" tumors "hot," and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Unlike many other "patient specific" immunotherapy approaches, our drugs are "off-the-shelf" which means that we can administer drug immediately without extracting patient material at a substantially lower cost of goods sold. Our TCAP product candidates from our ImPACT® and ComPACT(TM) platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers.
Register and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1